Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer

Max A K Rätze, Thijs Koorman, Thijmen Sijnesael, Blessing Bassey-Archibong, Robert van de Ven, Lotte Enserink, Daan Visser, Sridevi Jaksani, Ignacio Viciano, Elvira R M Bakker, François Richard, Andrew Tutt, Lynda O'Leary, Amanda Fitzpatrick, Pere Roca-Cusachs, Paul J van Diest, Christine Desmedt, Juliet M Daniel, Clare M Isacke, Patrick W B Derksen

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

Following the publication of this article, the authors noted an error in Fig. 6C. The merged (bottom left) panel for the human ILC organoid KCL320, did not display the correct z-plane. The correct merged image has now been provided. The authors confirm this does not affect the conclusions of the study in any way.

Original languageEnglish
Pages (from-to)3507-3509
Number of pages3
JournalOncogene
Volume41
Issue number26
Early online date24 May 2022
DOIs
Publication statusPublished - 24 Jun 2022

Fingerprint

Dive into the research topics of 'Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer'. Together they form a unique fingerprint.

Cite this